Posts

New joint French-U.S. laboratory to advance fundamental...

EAST LANSING, Mich. — Michigan State University (MSU) and the French research or...

New geometric deep learning model for detecting stroke ...

Ischemic stroke, which occurs when a blood vessel in the brain gets blocked by a...

Staying sharp: Researchers turn to an everyday shop too...

Researchers at Texas A&M University are taking a traditional manufacturing tool ...

Learning from superheroes and AI: UW researchers study ...

At first, some parents were wary: An audio chatbot was supposed to teach their k...

Consortium explores energy-efficient electronics and ph...

The University of Texas at Arlington is part of a new consortium funded by the D...

Plenary closeup: Biomolecular condensates the foundatio...

Biomolecular condensates, the tiny combinations of proteins and mRNA forming mem...

Unraveling the mystery of semi-extractable RNAs from hu...

Membraneless organelles (MLOs), also known as “biomolecular condensates,” are fo...

3D/4D printed bio-piezoelectric smart scaffolds for nex...

Piezoelectricity in native bones has been well recognized as the key factor in b...

NUS researchers develop novel approach for predicting r...

A team of researchers from the Cancer Science Institute of Singapore (CSI Singap...

3D digital technologies tackling mental injury preventi...

The Safety Sensescaping project, funded by WorkSafe’s WorkWell Mental Health Imp...

Concentration of cell membrane components with nanocarb...

Overview Credit: COPYRIGHT (C) TOYOHASHI UNIVERSITY OF TECHNOLOGY. ALL RIGHTS RE...

New theory developed for periodically driven quantum do...

A team led by Prof. GUO Guoping and Prof. CAO Gang from the University of Scienc...

Acumen’s Next-Gen Leqembi Rival Shows Promise in Early ...

Acumen Pharmaceuticals recently unveiled early clinical evidence showcasing the ...

Antengene’s multiple myeloma therapy receives approval ...

Antengene has received approval in Hong Kong for a new drug application (NDA) fo...

Vivoryon issues updates on its Alzheimer’s therapy prog...

The complete data readouts of two-Phase II trials are expected in 2024, with an ...

Korro Bio enters merger deal with Frequency Therapeutics

Korro Bio has signed a definitive merger agreement with Frequency Therapeutics t...